IC
BSX icon

Inscription Capital’s Boston Scientific BSX Stock Holding History

Inscription Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
+9,073
New +$493K 0.03% 469
2026
Q1 		– Sell
-2,894
Closed -$276K – 732
2025
Q4 		$276K Sell
2,894
-3,780
-57% -$371K 0.03% 509
2025
Q3 		$652K Buy
6,674
+2,252
+51% +$233K 0.07% 285
2025
Q2 		$475K Buy
+4,422
New +$447K 0.07% 225

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Inscription Capital's BSX Position: Q2 2026 in Review

Inscription Capital opened a new position in Boston Scientific (BSX) in Q2 2026: 9,073 shares worth $387K. The stake represents 0.03% of the portfolio and ranks #469 among its holdings. This is a return to the name: Inscription Capital previously reported a position in BSX as recently as Q4 2025.

Inscription Capital first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $652K in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Inscription Capital held 9,073 shares of Boston Scientific worth $387K as of Q2 2026.
  • Boston Scientific was a new Inscription Capital position in Q2 2026.
  • Boston Scientific made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #469 holding.
  • Inscription Capital first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • Inscription Capital's Boston Scientific position peaked at $652K in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.